NASDAQ : CODX
Co-Diagnostics, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.3667 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.91M |
| Enterprise Value | 1.06M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 7.95M |
| Shares Outstanding | 7.95M |
| Shares Change (YoY) | +130.53% |
| Shares Change (QoQ) | +91.26% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 8.29% |
| Float | 7.83M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.04 |
| Forward PS | 8.52 |
| PB Ratio | 0.14 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.81 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -174.77% |
| Return on Assets (ROA) | -59.63% |
| Return on Invested Capital (ROIC) | -290.60% |
| Return on Capital Employed (ROCE) | -219.15% |
| Weighted Average Cost of Capital (WACC) | 12.50% |
| Revenue Per Employee | $6,273 |
| Profits Per Employee | -$409,186 |
| Employee Count | 115 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.42 |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.62M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.90 |
| 52-Week Price Change | -97.52% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 2.20 |
| Relative Strength Index (RSI) | 18.84 |
| Average Volume (20 Days) | 495,620 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 656,373 |
| Short Previous Month | 418,934 |
| Short % of Shares Out | 8.26% |
| Short % of Float | 8.38% |
| Short Ratio (days to cover) | 1.62 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 721,386 |
| Gross Profit | 313,634 |
| Operating Income | -30.08M |
| Pretax Income | -48.68M |
| Net Income | -47.06M |
| EBITDA | -29.09M |
| EBIT | -30.08M |
| Loss Per Share | -$19.36 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.65M |
| Total Debt | 1.80M |
| Net Cash | 1.85M |
| Net Cash Per Share | $0.23 |
| Equity (Book Value) | 12.71M |
| Book Value Per Share | 2.61 |
| Working Capital | 2.33M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -27.10M |
| Capital Expenditures | -367,372 |
| Depreciation & Amortization | 992,234 |
| Net Borrowing | n/a |
| Free Cash Flow | -27.47M |
| FCF Per Share | -$3.46 |
Margins
| Measure | Value |
|---|
| Gross Margin | 43.48% |
| Operating Margin | -4,170.14% |
| Pretax Margin | -6,747.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -130.53% |
| Shareholder Yield | -130.53% |
| Earnings Yield | -5,278.90% |
| FCF Yield | -942.62% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 357.25% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -11.91 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |